col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


32 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Intensive Care Medicine Experimental
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―04 Plasma endostatin at intensive care admission is independently associated with acute kidney injury, dialysis, and mortality in COVID-19 Hazem Koozi, Jonas Engström, Ahmad Zwawi, Martin Spångfors, Ingrid Didriksson, Anders Larsson, et al. (+2)
2 [GO] 2025―Mar―07 The effects of urine alkalinization on kidney function in critically ill patients with COVID-19: a proof-of-concept randomized clinical trial Nuttha Lumlertgul, John A. Kellum, Jonah Powell-Tuck, Moncy Mathew, Sunita Sardiwal, Marlies Ostermann
3 [GO] 2025―Feb―07 Can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: the CHARTER-Ireland phase Ib/IIa, randomised, parallel-group, open-label study David Cosgrave, Bairbre McNicholas, Ciara Hanley, John Robert Sheehan, Padraig Calpin, Maeve Kernan, et al. (+16)
4 [GO] 2024―Sep―28 Association of corticosteroid therapy with reduced acute kidney injury and lower NET markers in severe COVID-19: an observational study Sara Bülow Anderberg, Joram Huckriede, Michael Hultström, Anders Larsson, Femke de Vries, Miklos Lipcsey, et al. (+2)
5 [GO] 2024―Aug―26 Fugitive medical and patient-derived aerosol particle distribution following heparin nebulization in patients with COVID-19 acute hypoxemic respiratory failure: a secondary analysis of the CHARTER study Michael Walsh, Marc Mac Giolla Eain, Ronan MacLoughlin, John Laffey, Bairbre McNicholas
6 [GO] 2024―Apr―22 Epstein-Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19 Alessia Mattei, Lorenzo Schiavoni, Elisabetta Riva, Massimo Ciccozzi, Roberta Veralli, Angela Urselli, et al. (+7)
7 [GO] 2024―Mar―07 The association between coronary artery calcification and vectorcardiography in mechanically ventilated COVID-19 patients: the Maastricht Intensive Care COVID cohort Eda Aydeniz, Frank van Rosmalen, Jip de Kok, Bibi Martens, Alma M. A. Mingels, Mustafa Emin Canakci, et al. (+7)
8 [GO] 2023―Nov―30 Circulating endothelial extracellular vesicle signatures correspond with ICU requirement: an exploratory study in COVID-19 patients Johannes Zipperle, Johannes Oesterreicher, Matthias Hackl, Teresa Lara Krammer, Helena Thumfart, Madhusudhan Reddy Bobbili, et al. (+10)
9 [GO] 2023―Oct―14 Neurovirulent cytokines increase neuronal excitability in a model of coronavirus-induced neuroinflammation Salil R. Rajayer, Stephen M. Smith
10 [GO] 2023―Oct―06 Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases Nazlıhan Boyacı Dündar, David Sarphie, Kenan Yüce, Ümmügülsüm Gaygısız, O. Tolga Kaskatı, Melda Türkoğlu, et al. (+7)
11 [GO] 2023―Sep―28 Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study Theodor Sievert, Ingrid Didriksson, Martin Spångfors, Gisela Lilja, Kaj Blennow, Henrik Zetterberg, et al. (+2)
12 [GO] 2023―Aug―13 Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients Sébastien Gibot, Thomas Lafon, Laurent Jacquin, Benjamin Lefevre, Antoine Kimmoun, Anne Guillaumot, et al. (+11)
13 [GO] 2023―Aug―06 Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study Nicolas de Prost, Etienne Audureau, Sébastien Préau, Raphaël Favory, Aurélie Guigon, Pierre Bay, et al. (+42)
14 [GO] 2023―Jun―18 Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a and antidrug antibodies in PANAMO: a phase 3 study in critically ill,  invasively mechanically ventilated COVID-19 patients Endry H. T. Lim, Alexander P. J. Vlaar, Sanne de Bruin, Simon Rückinger, Claus Thielert, Maria Habel, et al. (+83)
15 [GO] 2023―Jun―11 Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation Daniel A. Hofmaenner, David Furfaro, Lennart C. Wild, Pedro David Wendel-Garcia, Elias Baedorf Kassis, Ameeka Pannu, et al. (+10)
16 [GO] 2023―May―25 False-positive Legionella pneumophila antibodies in COVID-19 patients Shu-hua He, Shan Li, Li Weng
17 [GO] 2023―Feb―24 Elevated free interleukin-18 associated with severity and mortality in prospective cohort study of 206 hospitalised COVID-19 patients Syed M. T. Nasser, Anas A. Rana, Rainer Doffinger, Andreas Kafizas, Tauseef A. Khan, Shuaib Nasser
18 [GO] 2022―Dec―31 Methylprednisolone pulses as an initial treatment in hyperinflammatory syndrome after COVID-19 in children: evaluation of laboratory data, serial echocardiography and outcome: a case series Payman Sadeghi, Mojtaba Gorji, Raheleh Assari, Fatemeh Tahghighi, Seyed Reza Raeeskarami, Vahid Ziaee
19 [GO] 2022―Sep―18 Development and validation of an early warning model for hospitalized COVID-19 patients: a multi-center retrospective cohort study Jim M. Smit, Jesse H. Krijthe, Andrei N. Tintu, Henrik Endeman, Jeroen Ludikhuize, Michel E. van Genderen, et al. (+18)
20 [GO] 2022―May―24 Flow-controlled ventilation in moderate acute respiratory distress syndrome due to COVID-19: an open-label repeated-measures controlled trial Eleni D. Van Dessel, Gregory R. De Meyer, Stuart G. Morrison, Philippe G. Jorens, Tom Schepens
21 [GO] 2021―Oct―17 Data automated bag breathing unit for COVID-19 ventilator shortages Aleksandra B. Gruslova, Nitesh Katta, Andrew G. Cabe, Scott F. Jenney, Jonathan W. Valvano, Tim B. Phillips, et al. (+9)
22 [GO] 2021―Sep―03 Progranulin signaling in sepsis, community-acquired bacterial pneumonia and COVID-19: a comparative, observational study Florian Brandes, Melanie Borrmann, Dominik Buschmann, Agnes S. Meidert, Marlene Reithmair, Markus Langkamp, et al. (+15)
23 [GO] 2021―Sep―03 Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019 Vadim Lesan, Moritz Bewarder, Carlos Metz, André Becker, Sebastian Mang, Evi Regitz, et al. (+10)
24 [GO] 2021―Jun―27 Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse Lucas M. Fleuren, Michele Tonutti, Daan P. de Bruin, Robbert C. A. Lalisang, Tariq A. Dam, Diederik Gommers, et al. (+119)
25 [GO] 2021―Mar―23 Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? Patrick M. Honore, Sebastien Redant, David De Bels
26 [GO] 2021―Mar―15 Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients Chaoyang Sun, Yuzhe Sun, Ping Wu, Wencheng Ding, Shiyou Wang, Jiafeng Li, et al. (+15)
27 [GO] 2021―Feb―09 COVID-19 and VILI: developing a mobile app for measurement of mechanical power at a glance Angelo Senzi, Marco Bindi, Iacopo Cappellini, Lucia Zamidei, Guglielmo Consales
28 [GO] 2021―Jan―25 Lung ultrasound and computed tomography to monitor COVID-19 pneumonia in critically ill patients: a two-center prospective cohort study Micah L. A. Heldeweg, Jorge E. Lopez Matta, Mark E. Haaksma, Jasper M. Smit, Carlos V. Elzo Kraemer, Harm-Jan de Grooth, et al. (+5)
29 [GO] 2021―Jan―18 Serum cytokines profile of critically ill COVID-19 patients with cardiac dysfunction François Bagate, Nicolas Maziers, Sophie Hue, Paul Masi, Armand Mekontso Dessap, Nicolas de Prost
30 [GO] 2020―Dec―07 Endotoxemia and circulating bacteriome in severe COVID-19 patients Phatadon Sirivongrangson, Win Kulvichit, Sunchai Payungporn, Trairak Pisitkun, Ariya Chindamporn, Sadudee Peerapornratana, et al. (+26)
31 [GO] 2020―Nov―23 SARS-CoV-2 analysis on environmental surfaces collected in an intensive care unit: keeping Ernest Shackleton’s spirit Dolores Escudero, José Antonio Boga, Javier Fernández, Lorena Forcelledo, Salvador Balboa, Rodrigo Albillos, et al. (+6)
32 [GO] 2020―Sep―15 The conundrum of using hyperoxia in COVID-19 treatment strategies: may intermittent therapeutic hyperoxia play a helpful role in the expression of the surface receptors ACE2 and Furin in lung tissue via triggering of HIF-1α? Andreas Koch, Wataru Kähler, Sebastian Klapa, Bente Grams, Pieter- Jan A. M. van Ooij
 [1] 

32 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec